| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8dc4573446f32fa18760e1d2c32fdcf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ee33b0e3e7398cf6fc957eeee59d510
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77871063f98a212d925027b41cc5badb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98af37cb4fb0cd21e650b64dc403645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a058d7db4e4714671f1f3d939ee4808f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee4bf7cf548de48a55ed5ac7c594dd97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ddc2e778ed7dd7006d62125e0b4c82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1aa1d25d21d4f64eb9f5daf645819fdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a432a6a0e7b461a3c392479b9f5ff084 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
2012-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77dbb2c073d8532d783e51ed0344bb6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9963455ce421608694e5d119d1b3ca78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b28b0117490b8d08ca86af72bb70e2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_223552a4169dc3cb8dce45f6db652ce5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0923a239021ff47c0a30cc5c94196283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8778a591ebe6abde92e041277c41399
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cb2cdb9d8265c3e67960f4e458be485 |
| publicationDate |
2020-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10647968-B2 |
| titleOfInvention |
Endostatin mutants with mutations at ATP binding sites |
| abstract |
The present invention discloses a new anti-tumor medicament comprising a mutant of endostatin. The mutant comprises a mutation in the ATP-binding site of endostatin and has a decreased ATPase activity and an increased anti-angiogenesis activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022409703-A1 |
| priorityDate |
2011-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |